Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.

Clinical trial NCT05462379 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05462379
Sponsor: MARILIA ALBANEZI BERTOLAZZI
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cervical Carcinoma Premature Ovarian Failure

Start date: 2022-06-08
Primary completion: 2025-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.